Recent Developments in Retroviral-Mediated Gene Transduction

Slides:



Advertisements
Similar presentations
HIV Structure, Lifecycle, and Replication
Advertisements

Genome Structure of Retroviruses
HIV molecular biology BTY328: Virology
Gene Transfer. Comparison of different viral vectors Viral vectortitersmanupilation of immunogenicityinfecting of tropism non-dividing cells Adenovirus10.
Retroviral Gene Therapy. What is Gene Therapy? Gene Therapy Strategies.
Source: A DULTS AND C HILDREN L IVING WITH HIV/AIDS (Est. Dec 2007) deaths: 2,900,000 in ,100,000 in 2007 new cases: 2,500,000 in.
Lantiviral Vectors Fazal Tabassam Ph.D Feb.16,2009.
Schematic representation of mechanisms of activation of a host gene by insertion of a provirus and the general structure of leukemia and leukosis and acute.
Volume 15, Issue 6, Pages (June 2007)
Volume 16, Issue 3, Pages (March 2008)
Gene therapy: efficient targeting of hematopoietic stem cells
Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics  Toshio Kitamura, Yuko Koshino, Fumi Shibata, Toshihiko.
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Molecular Therapy - Nucleic Acids
Retroviral vector propagation in helper cells and structure of a prototypical vector. Retroviral vector propagation in helper cells and structure of a.
Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes by Julie Dyall, Jean-Baptiste.
Volume 12, Issue 4, Pages (October 2005)
Volume 159, Issue 5, Pages (November 2014)
Recent Developments in Retroviral-Mediated Gene Transduction
Volume 16, Issue 3, Pages (March 2008)
Volume 15, Issue 1, Pages (January 2007)
Volume 12, Issue 6, Pages (December 2005)
Volume 14, Issue 4, Pages (October 2006)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Transient Gene Expression by Nonintegrating Lentiviral Vectors
Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics  Toshio Kitamura, Yuko Koshino, Fumi Shibata, Toshihiko.
Spliceosome-Mediated RNA Trans-splicing
Volume 10, Issue 1, Pages (July 2004)
Gene Therapy for β-Hemoglobinopathies
Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)‏ by Michaela Scherr, Anuhar Chaturvedi, Karin.
Volume 12, Issue 6, Pages (December 2005)
Stable Transcriptional Repression and Parasitism of HIV-1
Peroxisome Proliferator-Activated Receptor-α Is a Functional Target of p63 in Adult Human Keratinocytes  Silvia Pozzi, Michael Boergesen, Satrajit Sinha,
Volume 9, Issue 4, Pages (April 2004)
Generation of a Flexible Cell Line with Regulatable, High-Level Expression of HIV Gag/Pol Particles Capable of Packaging HIV-Derived Vectors  Sandra Sparacio,
VSV-G Envelope Glycoprotein Forms Complexes with Plasmid DNA and MLV Retrovirus-like Particles in Cell-free Conditions and Enhances DNA Transfection 
Helper virus-mediated downregulation of transgene expression permits production of recalcitrant helper-dependent adenoviral vector  Donna J Palmer, Nathan.
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Generation of a stable packaging cell line producing high-titer PPT-deleted integration- deficient lentiviral vectors  Peirong Hu, Yedda Li, Mark S Sands,
Kailin Xu, Hong Ma, Thomas J. McCown, Inder M. Verma, Tal Kafri 
Development of an HIV-Based cDNA expression cloning system
HIV-1 Vif: Counteracting Innate Antiretroviral Defenses
Volume 2, Issue 3, Pages (September 2000)
Inclusion of jaagsiekte sheep retrovirus proviral elements markedly increases lentivirus vector pseudotyping efficiency  Patrick L. Sinn, Erin R. Burnight,
Volume 10, Issue 4, Pages (October 2004)
Live and Let Die: A New Suicide Gene Therapy Moves to the Clinic
Volume 2, Issue 1, Pages (July 2000)
Volume 15, Issue 4, Pages (April 2007)
Generation and molecular characterization of LV producer cell lines
Production of lentiviral vectors
Volume 11, Issue 6, Pages (June 2005)
Volume 8, Issue 1, Pages (July 2010)
Volume 22, Issue 10, Pages (October 2014)
Cheryl A. Carlson, Dmitry M. Shayakhmetov, André Lieber 
Volume 4, Issue 6, Pages (December 2001)
Development of an HIV-Based cDNA expression cloning system
Viral and Synthetic RNA Vector Technologies and Applications
Volume 4, Issue 6, Pages (December 2001)
Volume 2, Issue 4, Pages (October 2000)
Volume 9, Issue 2, Pages (February 2004)
In Vivo Gene Delivery to Synovium by Lentiviral Vectors
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
Volume 9, Issue 5, Pages (May 2004)
Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner  Juan Lama, Aram Mangasarian,
Volume 6, Issue 1, Pages 5-11 (July 2002)
High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors  Yani Hu,
Volume 7, Issue 3, Pages (March 2003)
Volume 11, Issue 5, Pages (May 2005)
Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease
Hildegard Büning, Arun Srivastava 
Presentation transcript:

Recent Developments in Retroviral-Mediated Gene Transduction Gordon Daly, Yuti Chernajovsky  Molecular Therapy  Volume 2, Issue 5, Pages 423-434 (November 2000) DOI: 10.1006/mthe.2000.0211 Copyright © 2000 American Society for Gene Therapy Terms and Conditions

FIG. 1 Packaging of replication deficient retroviral vector in packaging cells. Packaging cells engineered to express retroviral structural genes devoid of packaging signal (ψ) are transfected with plasmids containing the retroviral vector which includes the ψ sequence. Upon transcription of the retroviral vector mRNA it gets packaged into viral particles which bud from the cell surface and can infect target cells. Molecular Therapy 2000 2, 423-434DOI: (10.1006/mthe.2000.0211) Copyright © 2000 American Society for Gene Therapy Terms and Conditions

FIG. 2 Basic structure of the plasmoviral vector system. The retroviral vector is flanked by LTRs and includes the ψ-packaging signal, Gag/Pol genes and a reporter gene or other gene of interest. 3’ to the vector, the plasmid contains a CMV transcriptional unit driving expression of amphotropic Env. As this Env is not included between the LTRs, the retrovirus packaged can not be transmitted to additional cells once incorporated into its primary target cell. Molecular Therapy 2000 2, 423-434DOI: (10.1006/mthe.2000.0211) Copyright © 2000 American Society for Gene Therapy Terms and Conditions

FIG. 3 Genome organization of HIV. Between the LTRs of HIV a complex genome expressing Gag, Pro/Pol, Vpr (R), Vif, Vpu (U), Tat, Rev, and Nef is assembled. Several splice donor and acceptor sites (shown as separating black flat surfaces) ensure the expression of several mRNAs capable of translating these gene products. The functions of these genes are discussed in the text. Molecular Therapy 2000 2, 423-434DOI: (10.1006/mthe.2000.0211) Copyright © 2000 American Society for Gene Therapy Terms and Conditions

FIG. 4 Schematic representation of the first-generation lentiviral vector system developed by Naldini et al. (107). The three plasmid system consists of two packaging plasmids. One expresses either the VSV-G protein or the amphotropic Env gene, the second provides all HIV proteins excluding Env and Vpu and cannot encapsidate as has its ψ element deleted. The third plasmid is the lentiviral transfer vector per se containing between the LTRs the ψ sequence with a truncated Gag gene out of frame, an RRE element for efficient nuclear transport and an internal CMV promoter for expression of a gene of interest. Molecular Therapy 2000 2, 423-434DOI: (10.1006/mthe.2000.0211) Copyright © 2000 American Society for Gene Therapy Terms and Conditions